Deltex Medical – interims emphasise “returns to growth”. Er, what about the balance sheet woes?!
Previously writing on medical monitoring technology group Deltex Medical (DEMG), in July with the shares down to 1.10p I wrote emphasises higher revenue, but how’s the balance sheet?!. What of now results for the first half of 2022 and a 0.925p share price?
- By Steve Moore
- 2022-09-20 14:49:56